4//SEC Filing
William Arsani 4
Accession 0001415889-25-021842
CIK 0001807120other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 4:15 PM ET
Size
7.4 KB
Accession
0001415889-25-021842
Insider Transaction Report
Form 4
William Arsani
Director
Transactions
- Sale
Common Stock
2025-08-13$5.25/sh−345,000$1,811,250→ 2,655,000 total(indirect: By Logos Global Master Fund LP) - Sale
Common Stock
2025-08-13$5.25/sh−217,627$1,142,542→ 1,000,000 total(indirect: By Logos Opportunities Fund II LP)
Footnotes (2)
- [F1]Logos GP LLC ("Fund GP") is the general partner of Logos Global Master Fund LP (the "Fund"). The Reporting Person is the Managing Member of Fund GP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of Reporting Person's pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F2]Logos Global Management LP is the investment advisor of private funds, including Logos Opportunities Fund II LP ("LOF II"). Logos Opportunities GP LLC ("GP I") is the general partner of LOF II. The Reporting Person is the Managing Member of GP I. The Reporting Person disclaims beneficial ownership of these securities except to the extent of Reporting Person's pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Documents
Issuer
Design Therapeutics, Inc.
CIK 0001807120
Entity typeother
Related Parties
1- filerCIK 0001848372
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 4:15 PM ET
- Size
- 7.4 KB